Focal adhesion kinase (FAK) signaling may be mediated through the modulation of Ras activity. We have shown previously that grade III malignant astrocytoma biopsy samples exhibit elevated levels of FAK, and that overexpression of FAK in U-251MG malignant astrocytoma cells promotes the phosphorylation of Shc, a potential upstream mediator of Ras activity. Here, we report that overexpression of FAK promotes Ras activity in U-251MG malignant astrocytoma cells cultured in aggregate suspension or as monolayers adherent to vitronectin. The overexpression of FAK also promoted the association of FAK with p120RasGAP, which is a negative regulator of Ras activity, in the U-251MG cells cultured in aggregate suspension, with this association being abrogated upon plating of the cells onto vitronectin. An association of FAK with p120RasGAP also was observed in malignant astrocytoma biopsy samples, but not in normal brain samples. As overexpression of FAK in U-251MG cells in aggregate suspension culture reduced the amount of p120RasGAP complexed with active Ras, we hypothesize that the association of FAK with p120 RasGAP may facilitate Ras activity. The overexpression of a mutated FAK in which the Y397 had been mutated to F did not result in the formation of the FAK/p120Ras-GAP complex and did not promote Ras activity, indicating that the Y397 residue of FAK plays a role in the formation of this complex and in the activation of Ras. Moreover, the overexpression of mutated FAK (397F) was found to inhibit anchorage-independent growth. These data provide the basis for a previously undescribed mechanism in which the elevated expression of FAK can promote Ras activity through its competitive recruitment of p120RasGAP, thereby diminishing the association of p120RasGAP with active Ras.
Introduction
Patients with grade III malignant astrocytomas have a median survival of 3 years, and those with grade IV malignant astrocytomas have a median survival of only 1 year (Kleihues et al., 1993) . This dismal prognosis is associated, at least in part, with the invasive behavior of these brain tumors and their high rate of proliferation. We have found previously that the proliferation of these tumors both in vitro and in vivo is promoted by focal adhesion kinase (FAK) (Wang et al., 2000) . Specifically, overexpression of FAK in U-251MG malignant astrocytoma cells resulted in increased anchorage-independent growth in vitro and increased proliferation when these cells were propagated intracerebrally in the brains of C.B.17 SCID mice (Wang et al., 2000) . Ras also has been implicated in the proliferation of astrocytes. It has been shown that transgenic mice expressing constitutively active Ras under the control of an astrocytespecific promoter exhibit astrocyte proliferation in vivo (Guha et al., 1997; Ding et al., 2001) . In addition, Ras activity has been reported to be elevated in malignant astrocytoma biopsy samples in the absence of Ras gainof-function mutations (Guha, 1998) .
It is well established that the levels of activity of Ras reflect the net effect of positive and negative regulators in various different cell types (Bar-Sagi and Hall, 2000) . Proteins, such as Shc and Grb2, that are positive regulators affect the activation of Ras through their association with SOS, thereby enabling Ras-GTP loading. Phosphorylation of Shc is necessary for the association of Grb2 and SOS (Luzi et al., 2000) . We have shown previously that the overexpression of FAK in malignant astrocytoma cells results in enhanced phosphorylation of Shc in vitro, and that the levels of phosphorylation of Shc in malignant astrocytoma biopsy samples are higher than in the normal brain (Hecker et al., 2002) . Thus, elevated levels and activity of FAK could lead to increased Ras activity through the increased phosphorylation of Shc.
Negative regulators of Ras, including p120RasGAP, associate directly with activated Ras and stimulate GTP hydrolysis (Tocque et al., 1997; Bar-Sagi and Hall, 2000) . p120RasGAP contains protein-interacting domains (two SH2 and one SH3 domain) within its aminoterminus that mediate protein-protein interactions with other molecules (e.g. p190RhoGAP and p62Dok) (Ellis et al., 1990; Tocque et al., 1997) . p120RasGAP interacts with p190RhoGAP through an SH2 domain(s). These domains are thought to provide an effector function for Ras signaling, although the role of the amino-terminal region of p120RasGAP in Ras signaling is not understood fully (Tocque et al., 1997) .
Here, we further analysed the effects of the overexpression of FAK in malignant astrocytoma cells in order to determine the role of FAK in the promotion of Ras-GTP loading. The effects were analysed in the malignant astrocytoma cell line U-251MG cultured in aggregate suspensions or as monolayers, and the physiological significance of the data then assessed in comparison with the data obtained from biopsy samples. Propagation of malignant astrocytoma cells or renal cell carcinoma cells as clusters or spheroids results in cell behavior that closely resembles tumor cell proliferation and invasion in vivo (Lieubeau-Teillet et al., 1995; Mohan et al., 1999) . We found that overexpression of FAK is sufficient to increase Ras activity (Ras-GTP loading) in the U-251MG cells grown in aggregate suspension or as monolayer cultures. In U-251MG cells grown in aggregate suspension culture, the elevated expression of FAK promotes the association of FAK with p120RasGAP, and a similar association was observed in the malignant astrocytoma brain biopsy samples. The association was found to require tyrosine residue 397 of FAK. This association of FAK with p120RasGAP most likely contributes to enhanced Ras activity by the competitive recruitment of p120RasGAP, thereby diminishing its association with activated Ras, and suggests a previously undescribed mechanism by which elevated levels of FAK protein and activity may enhance Ras activity and contribute to the proliferation of malignant astrocytoma cells in vivo.
Results
Overexpression of FAK is sufficient to promote Ras-GTP loading in malignant astrocytoma cells propagated in aggregate suspension or monolayer cultures
We first determined as to whether overexpression of FAK is sufficient to promote Ras activity in malignant astrocytoma cells. The malignant astrocytoma cells, the OFAK5 clone of U-251MG cells, used in this study are stably transfected with wild-type FAK using the TETinducible system and have been characterized previously (Wang et al., 2000) . The activity of Ras was estimated by pull-down assays of the cell lysate with Raf-RBDconjugated beads, followed by Western blot analysis using mAb anti-Ras. Cells were treated with 0.1 mg/ml doxycycline for 4 days, harvested, resuspended in serumfree media and propagated in aggregate suspension for 1 h, or plated onto vitronectin-coated plates as a monolayer for 1 h. A fivefold increase in FAK expression was observed both in the cells propagated in aggregate suspension culture and in those that were plated (Figure 1a ). Under these conditions, the overexpression of FAK also resulted in increased phosphorylation of Y397 in both the cells propagated in aggregate Figure 1 Overexpression of FAK promotes Ras activity in malignant astrocytoma cells under all culture conditions. (a-h) OFAK5 cells were treated with 0.1 mgml of doxycycline ( þ ) or no doxycycline (À) for 4 days, harvested and cultured in aggregate suspension in serum-free media for the indicated time, or plated onto vitronectin-coated plates for the indicated time, followed by detergent lysis. (a-c) Lysate was sequentially blotted with anti-FAK IgG (a), anti-FAK [pY397] IgG (b), and mAb anti-actin (c). (d and g) Pull-down assays of the lysate were performed with Raf-RBD-conjugated beads, followed by blotting with mAb anti-Ras at 1 h (d) and 24 h (g). (e and h) Lysate was blotted with mAb antiRas. The results shown are representative of three independent experiments. (f) Statistical analysis of the densitometric readings for the Ras activity at 1 h employing a two-tailed t-test: OFAK5 cells cultured in aggregate suspension that were treated with doxycycline (0.2970.04; mean7s.e.m.) as compared to untreated cells (0.1270.03), P-value ¼ 0.01; and OFAK5 cells plated onto vitronectin that were treated with doxycycline (0.1870.02; mean7s.e.m.) as compared to the untreated cells (0.0870.006), P-value ¼ 0.03 FAK/p120RasGAP complex promotes Ras activity TP Hecker et al suspension and the plated cells (Figure 1b) . Moreover, the increased activity of FAK was correlated with an increased level of Ras in the active GTP-bound form in both conditions (Figure 1d and e). Analysis of the densitometric readings showed the Ras activity to be increased by approximately threefold in the OFAK5 cells treated with doxycycline and cultured in aggregate suspension, as compared to the untreated cells; Pvalue ¼ 0.01 (Figure 1f ). In the OFAK5 cells treated with doxycycline and plated onto vitronectin, a twofold increase in Ras activity was found, as compared to the untreated cells; P-value ¼ 0.03 (Figure 1f ). These studies were repeated with a second clone (OFAK9) of U-251MG cells stably transfected with wild-type FAK that has been characterized previously (Wang et al., 2000) , and the results were identical. The overexpression of FAK remained correlated with elevated levels of Ras-GTP in both culture conditions at 6 and 24 h (Figure 1g and h, 24 h time point shown). Thus, the overexpression of FAK is sufficient to promote Ras-GTP loading in malignant astrocytoma cells in vitro.
Overexpression of FAK promotes its association with p120RasGAP in malignant astrocytoma cells propagated in aggregate suspension culture: the FAK/p120RasGAP association is abrogated upon plating the cells onto vitronectin
To determine whether the FAK protein associates with p120RasGAP in malignant astrocytoma cells as has been reported for the rat embryonic brain (Serpente et al., 1996) , OFAK5 cells were treated with doxycycline as described above, cultured in aggregate suspension or plated onto vitronectin and then analysed by immunoprecipitation with mAb anti-p120RasGAP, followed by Western blotting using rabbit anti-FAK IgG. The overexpression of FAK in cells propagated in aggregate suspension culture for 1, 6 or 24 h resulted in the association of FAK with p120RasGAP ( Figure 2a and b, lanes 1 and 2, 1 h time point shown). In contrast, this association of FAK with p120RasGAP was not detectable in cells plated onto vitronectin as a monolayer for 1, 6 or 24 h (Figure 2a and b, lanes 3 and 4, 1 h time point shown). These data suggest that the overexpression of FAK in malignant astrocytoma cells promotes the association of FAK with p120RasGAP when these cells are propagated in aggregate suspension culture.
Analysis of the association of p120RasGAP with p190RhoGAP, a protein with a well-characterized association with p120RasGAP, indicated that plating of OFAK5 cells overexpressing FAK onto immobilized vitronectin resulted in the association of p120RasGAP with p190RhoGAP at 15 and 30 min, with a reduction in association occurring by 1 h (Figure 2e) . Thus, the p120RasGAP in the plated cells is capable of undergoing functional interactions through its SH2 domain(s) even though an association with FAK is not observed (Figure 2c-f) . In contrast, an association of p120Ras-GAP with p190RhoGAP was not observed in cells propagated in aggregate suspension culture for 45 min (Figure 2e , lane 1), suggesting that the interaction of p120RasGAP with FAK in cells maintained in aggregate suspension is unlikely to be due to a random interaction.
The same coimmunoprecipitation followed by Western blotting technique was used to determine the association of FAK with p120RasGAP in six malignant astrocytoma biopsy samples (anaplastic astrocytoma, grade III) and six normal brain biopsy samples (two from patients with a seizure disorder and increased numbers of benign astrocytes and four from normal Immunoprecipitation with mAb anti-p190RhoGAP, followed by blotting with mAb anti-p120RasGAP (e), and reprobing with mAb anti-p190RhoGAP (f). (g-j) Human normal brain biopsy samples and human anaplastic astrocytoma biopsy samples were detergent lysed, and 400 mg of lysate immunoprecipitated with mAb or rabbit anti-p120RasGAP and subjected to SDS-PAGE, or 20 mg of lysate subjected to SDS-PAGE, followed by blotting with rabbit anti-FAK IgG (g and i), and reprobing with anti-p120RasGAP IgG (h and j). The results shown are representative of three independent experiments FAK/p120RasGAP complex promotes Ras activity TP Hecker et al adult brains at autopsy). We found p120RasGAP to be associated with FAK in all six anaplastic astrocytoma biopsy samples (Figure 2g -j, four samples shown). However, p120RasGAP was not associated with FAK in any of the six normal brain samples ( Figure 2g -j, four samples shown). To estimate the relative amount of FAK associated with p120RasGAP, electrophoresis of 20 mg of normal brain or tumor lysate adjacent to the immunoprecipitated p120RasGAP (from 400 mg of lysate), followed by immunoblotting for FAK and densitometric analysis of the resultant band consistent with FAK was performed. Based on a twofold greater intensity of the FAK band in the p120RasGAP IPs from the tumor samples, as compared to the adjacent FAK band in the electrophoresed tumor lysates, and the fact that a 20-fold greater amount of lysate was subjected to the p120RasGAP IPs as compared to the electrophoresed tumor lysates, we estimate that approximately 10% of the total FAK is associated with p120RasGAP in the tumor samples ( Figure 2i , two samples shown). In addition, the relative level of p120RasGAP protein appeared to be similar in the six anaplastic astrocytoma and six normal brain biopsy samples ( Figure 2g -j, four samples of tumor and four samples of normal brain shown). These data indicate that FAK is associated with p120RasGAP in malignant astrocytoma tumors in vivo and provides further support for the physiologic relevance of the results obtained using cells cultured in aggregate suspension.
SH2 domain of p120RasGAP mediates the association with FAK
In the developing rat brain, the association of p120Ras-GAP with FAK is mediated through the SH2 domain(s) of p120RasGAP (Serpente et al., 1996) . To determine which domain of p120RasGAP mediates the association with FAK in malignant astrocytoma cells, we performed pull-down assays with the recombinant SH2 and SH3 domains of p120RasGAP from the lysate of OFAK5 cells induced to overexpress FAK, followed by blotting with mAb anti-c-myc (FAK tag). After propagation in aggregate suspension culture for 1 h, pull-down assays with the amino-terminal SH2 domain of p120RasGAP demonstrated an association with FAK, suggesting it mediates the association of p120RasGAP with FAK ( Figure 3a , lane 1). Pull-down assays performed with the carboxyl-terminal SH2 domain of p120RasGAP did not show an association with FAK, and pull-down assays with the SH3 domain of p120RasGAP showed only a minimal association with FAK (Figure 3a ). To confirm that the two proline-rich regions of FAK do not mediate to a significant degree the association with p120Ras-GAP, we transiently transfected the U-251MG cells with hemaglutinin (HA)-tagged FRNK, which is the carboxyl-terminal region of FAK that contains the two proline-rich regions. We found that endogenous p120RasGAP could not be coimmunoprecipitated with FRNK in the U-251MG cells propagated in aggregate suspension for 1 h (Figure 3c and d) , suggesting that under these conditions p120RasGAP does not associate with the proline-rich regions of FAK.
To determine if a phosphorylated tyrosine residue(s) in FAK potentially mediated the association with p120RasGAP in malignant astrocytoma cells, we analysed the lysate of cells induced to overexpress FAK using Western blotting with phosphospecific anti-FAK antibodies. The overexpression of FAK in cells propagated in aggregate suspension resulted in elevated phosphorylation of Y397, Y407 and Y861 (Figure 3e-h) , thereby identifying these tyrosine residues of FAK as FAK/p120RasGAP complex promotes Ras activity TP Hecker et al candidate mediators of the interaction of FAK with p120RasGAP. Notably, no phosphorylation of Y925, which can promote Ras activation through Grb2 binding (Schlaepfer et al., 1994) , was detected (data not shown).
Src also associates with FAK at Y397 in adherent cells (Schaller et al., 1994; Xing et al., 1994) and Src has been shown to associate with p120RasGAP (Brott et al., 1991) . We therefore investigated the potential interaction of p120RasGAP with Src in the OFAK5 cells after the induction of FAK and propagation in aggregate suspension culture for 1 h, and found that an SH2 domain(s) of p120RasGAP can associate with Src ( Figure 3b ). To determine whether Src associates with FAK in OFAK5 cells cultured in aggregate suspension and the effect of overexpression of FAK, we immunoprecipitated the lysate of cells cultured in aggregate suspension for 1 h, or adherent to vitronectin for 1 h, with mAb anti-Src IgG and then Western blotted for FAK. We found an Src/FAK association in the OFAK5 cells cultured in either condition, and doxycycline induction of FAK increased the relative total amount of FAK associated with Src (Figure 3j and k). These data suggest that the association of FAK with p120RasGAP that we have identified in the OFAK5 cells overexpressing FAK may not be direct and could involve Src as an intermediate molecule.
Overexpression of mutant FAK (397F) fails to result in FAK association with p120RasGAP: tyrosine residue 397 of FAK is necessary for the association with p120RasGAP
As Y397 of FAK mediates the SH2 domain interaction of Src with FAK (Schaller et al., 1994; Xing et al., 1994) , and p120RasGAP associates with Src in our cells, we investigated Y397 of FAK as a candidate mediator of the FAK interaction with p120RasGAP. Stable clones that overexpress c-myc-tagged FAK with a mutation of Y397 to phenylalanine (FAK-397F) were created from the U-251MG malignant astrocytoma cells using the TET-ON system. In all, 60 independent clonal cell lines were screened for mutant FAK-397F expression after doxycycline induction and three clones were selected for further study, along with one empty vector clone (TRE2). Two of the clones expressed high levels of mutant FAK (OFAK-397F-18 and -3) and one expressed a somewhat lower level of the mutated FAK (OFAK-397F-5) after induction (Figure 4a ). To confirm that overexpression of FAK-397F does not affect cell adhesion, attachment assays were performed using two different ligands. Doxycycline induction of the mutated FAK did not affect the attachment of the FAK-397F clones (Figure 4c) .
To determine the potential role of Y397 of FAK in mediating FAK association with p120RasGAP in cells propagated in aggregate suspension, the OFAK5 and OFAK-397F-3 clones were subjected to coimmunoprecipitation with mAb anti-p120RasGAP followed by Western blotting with rabbit anti-FAK IgG. Cells were treated with doxycycline for 4 days, harvested, resuspended in serum-free media and cultured in aggregate suspension for 1 h. Under these conditions, a three-to fivefold increase in wild-type FAK or FAK-397F was found ( Figure 5a ). As expected, overexpression of mutant FAK-397F did not result in the increased phosphorylation of Y397, although overexpression of wild-type FAK did result in increased phosphorylation (Figure 5b) . Notably, overexpression of mutant FAK (397F) did not result in an enhanced association of FAK with p120RasGAP (Figure 5d and e, lanes 3 and 4) , suggesting that Y397 of FAK mediates or is necessary for the FAK/p120RasGAP interaction. This finding is consistent with the FAK/p120RasGAP association 
FAK association with p120RasGAP facilitates Ras-GTP loading by competitively recruiting p120RasGAP, thereby diminishing its association with activated Ras
To determine the effect of the association of FAK with p120RasGAP on Ras activity, the OFAK5 and OFAK-397F-3 clones were analysed for Ras activity. Doxycycline was administered for 4 days, the cells were then harvested and resuspended in serum-free media in aggregate suspension culture for 1 h. Under these conditions, increased Ras-GTP loading in cells overexpressing wild-type FAK was observed (Figure 5f and h, lanes 1 and 2), whereas no effect on Ras-GTP loading was observed in the cells overexpressing mutant FAK-397F-3 (Figure 5f and h, lanes 3 and 4). Thus, the association of FAK with p120RasGAP temporally correlates with increased Ras activity. Moreover, Western blotting with mAb anti-p120RasGAP of the active Ras (pull-down assay with Raf-RBD-conjugated beads) showed that overexpression of wild-type FAK decreased the amount of p120RasGAP protein associated with active Ras (Figure 5g, lanes 1 and 2) , whereas the overexpression of mutant FAK-397F-3 (which does not associate with p120RasGAP) did not decrease the level of p120RasGAP associated with active Ras (Figure 5g, lanes 3 and 4) . Since the overexpression of wild-type FAK promotes p120RasGAP association with FAK in aggregate suspension culture and a concomitant decrease in p120RasGAP associated with active Ras, these data suggest that the overexpression of FAK enhances Ras activity, at least in part, by recruiting p120RasGAP away from Ras (see model, Figure 6 ).
Overexpression of mutant FAK-397F inhibits anchorageindependent growth of malignant astrocytoma cells
Ras activity has been shown to be an important mediator of cell transformation and to promote anchorage-independent growth (White et al., 1995; Renshaw et al., 1999; Bar-Sagi and Hall, 2000) . Anchorage-independent growth assays are thought to more closely mimic proliferation in vivo in the animal than monolayer cultures (Wang et al., 2000) . To determine the effect of mutant FAK-397F on anchorage-independent growth, doxycycline was administered to the OFAK-397F clones for 4 days prior to the anchorage-independent growth assay. We found a dose-dependent inhibition of anchorage-independent growth in OFAK-397F-18 and OFAK-397F-3 clones after doxycycline induction of the mutant FAK (Figure 4d ). This is in contrast to our previously published data overexpressing wild-type FAK, where increased anchorage-independent growth was observed (Wang et al., 2000) . 
Discussion
To determine the role of FAK in activating Ras in malignant astrocytoma cells, we investigated the effect that overexpression of FAK has on the activation of Ras (GTP loading) in malignant astrocytoma cells. We found that the overexpression of wild-type FAK in U-251MG malignant astrocytoma cells was sufficient, at all time points assayed, to increase Ras activity in cells in serum-free media propagated in aggregate suspension or when plated onto vitronectin as a monolayer. Furthermore, we have identified a novel FAK-mediated mechanism that appears to upregulate Ras activity only in cells cultured in aggregate suspension -the association of FAK with p120RasGAP, and this association requires Y397 of FAK. These data suggest that there is another mechanism for the increase in Ras activity in adherent cells overexpressing FAK. Our findings are relevant to the biology of malignant tumors as they suggest that elevated FAK expression and activity may be one mechanism leading to enhanced Ras activity in malignant astrocytoma tumors in vivo, consistent with our recent demonstration of elevated levels of FAK protein and activity in anaplastic astrocytoma biopsy samples (grade III tumors) (Hecker et al., 2002) , and it is possible that FAK enhancement of Ras activity also plays a role in the proliferation and/or migration of other types of tumors that express elevated levels of FAK protein, such as those of the head and neck and prostate cancer (Kornberg, 1998; Slack et al., 2001) . We demonstrate that the overexpression of FAK in malignant astrocytoma cells propagated in aggregate suspension promoted the association of FAK with p120RasGAP. This association of FAK with p120Ras-GAP was found in cells propagated in aggregate suspension, with plating onto vitronectin resulting in an abrogation of the FAK/p120RasGAP association. In cells induced to express higher levels of FAK protein through the use of an increased dosage of doxycycline (410-fold induction of FAK), the FAK/p120RasGAP association was significantly decreased but not completely diminished upon plating onto vitronectin as a monolayer (TP Hecker and CL Gladson, unpublished observation). In aggregate suspension culture or growth as a tumor spheroid, the tumor cells grow in a threedimensional environment but maintain cell-cell contacts, and it has been suggested that the behavior of the tumor cells in this environment more closely resembles their behavior in vivo than that observed on plating as a monolayer onto immobilized substrates (Lieubeau-Teillet et al., 1995) . Our finding that FAK protein associates with p120RasGAP in six anaplastic astrocytoma biopsy samples, but not in six normal brain biopsy samples, supports the relevance of investigating FAK signaling in tumor cells propagated in aggregate suspension culture.
Our finding that FAK protein associates with p120RasGAP in anaplastic astrocytoma biopsy samples, but not in non-neoplastic brain biopsy samples, also provides further evidence of a similarity between the function of FAK in malignant astrocytoma tumors and its function in the embryonic brain. We have shown previously that FAK in anaplastic astrocytoma tumor biopsy samples (grade III tumors) resembles FAK in the embryonic rat brain in the faster mobility of FAK on SDS-PAGE as compared to the normal adult brain, due to the lack of alternative splicing around Y397, the autophosphorylation site (Hecker et al., 2002) . Other investigators have reported that FAK can be coimmunoprecipitated with p120RasGAP in lysates from the embryonic rat brain and that an SH2 domain of p120RasGAP mediates this interaction (Serpente et al., 1996) . In the latter study, the tyrosine residue in FAK that is necessary for this interaction and the effect of this interaction on Ras activity were not explored. Future studies will analyse the potential association of FAK with p120RasGAP in various grades of astrocytoma tumors.
The overexpression of FAK in cells propagated in aggregate suspension not only correlated with increased Ras activity and FAK association with p120RasGAP but also decreased association of the p120RasGAP protein with active Ras. These results suggest that FAK association with p120RasGAP may promote Ras activity by competing with Ras for a p120RasGAP association (see model, Figure 6 ). This conclusion is supported by the finding that p120RasGAP promotes the inactivation of Ras by directly binding and stimulating the GTP hydrolysis of activated Ras via its GTPase domain (Trahey and McCormick, 1987; Marshall et al., 1989) . In support of our concept of p120RasGAP function, recent in vitro evidence of other investigators suggests that occupancy of the p120Ras-GAP's SH2 domain(s) may impair the GTPase-promoting activity of p120RasGAP toward Ras (Kashige et al., 2000; Cacalano et al., 2001) . For example, the binding of phosphorylated SOCS-3 to p120RasGAP has been reported to promote Ras activity; SOCS-3 is an inhibitor of cytokine signal transduction and STAT activation (Cacalano et al., 2001 ). In the latter study, it was not examined whether the association of SOCS-3 with p120RasGAP decreased the association of p120RasGAP with active Ras. Our data are further supported by reports that transfection of an aminoterminal construct of p120RasGAP (containing the two SH2 and one SH3 domain) inhibits Ras transformation and correlates with the ability of the amino-terminal p120RasGAP construct to compete with endogenous p120RasGAP for binding to p190Rho-GAP (Clark et al., 1997) .
It is possible that the novel mechanism for the enhancement of Ras activity by FAK occurs generally in vivo in conditions in which FAK is overexpressed, for example, tumors. We demonstrate in this paper that elevated FAK protein promotes Ras activity, and that in astrocytoma tumor cells cultured in aggregate suspension the association of p120RasGAP with FAK is likely one mechanism leading to the elevated Ras activity. Furthermore, we show that Src also associates with FAK in astrocytoma cells cultured in aggregate suspension, suggesting the FAK/p120RasGAP association could be indirect. Based on these findings, we propose the following two mechanistic models by which elevated Hecker et al., 2002) , the Grb2-SOS complex binding to the phosphorylated FAK Y925 site (Schlaepfer et al., 1994) or the Crk-SOS complex binding to phosphorylated p130CAS or paxillin (Kiyokawa et al., 1997; Polte and Hanks, 1997; Parsons et al., 2000) . All of these mechanisms have been identified in adherent cells and are dependent on Src binding to FAK. Src binds the phosphorylated Y397 site in FAK with high affinity, and in fibroblasts this interaction is regulated by cell adhesion (Schaller et al., 1994; Xing et al., 1994) . Our data do not exclude the possibility that p120RasGAP binds directly to phosphorylated Y407 or Y861 of FAK; this would require Src binding to phosphorylated Y397 and its phosphorylation of Y407 and Y861. Therefore, our data suggest that the elevated expression of FAK in tumor cells results in increased Ras activity, and in certain tumor cell environment/ culture conditions the increased Ras activity can be mediated through an association of FAK with p120Ras-GAP.
We have shown previously that stable overexpression of wild-type FAK promoted anchorage-independent growth of malignant astrocytoma cells (Wang et al., 2000) . This is consistent with our current finding that overexpression of wild-type FAK promotes Ras activity and p120RasGAP association with FAK. In contrast, we found here that the stable overexpression of the mutant FAK-397F inhibited the anchorage-independent growth of the malignant astrocytoma cells, and did not result in p120RasGAP association with FAK in cells propagated in aggregate suspension. Transient and stable overexpression of mutant FAK-397F in other cell types has been reported (Renshaw et al., 1999; Roy et al., 2002) . Stable overexpression of wild-type or mutant FAK (397F) in v-Src-transformed FAKÀ/À fibroblasts did not alter the ability of the cells to grow in soft agar (Roy et al., 2002) . These studies taken together suggest that FAK can have different effects in different cell types, which could relate to different mechanisms underlying the transformation of the cells. In other cell types, expression of this mutant FAK has been reported to inhibit the association of FAK with other molecules (i.e. Shc and Src) (Schlaepfer et al., 1998) , which could contribute to the inhibition of anchorage-independent growth.
Elevated Ras activity can lead to the activation of ERK (Crews and Erikson, 1993) , and, in fibroblasts, the overexpression of FAK promotes ERK activity, presumably through Ras (Schlaepfer et al., 1994 (Schlaepfer et al., , 1998 . We have shown previously that the overexpression of FAK in malignant astrocytoma cells is only sufficient to sustain ERK activity at a late time point (24 h) when the cells are plated as a monolayer onto vitronectin, and elevated ERK activity was not found in cells in aggregate suspension culture at the single, early (1 h) time point tested (Hecker et al., 2002) . It is, therefore, of interest that we detect elevated levels of Ras-GTP in cells overexpressing FAK at all time points and irrespective of their culture as aggregate suspensions or as monolayers. This would suggest that, in malignant astrocytoma cells, the physiological consequences of FAK signaling to Ras may differ under various conditions and that the downstream signals of Ras activation can diverge prior to ERK. The further analysis of the downstream signals from Ras in malignant astrocytoma cells cultured under various conditions is the focus of our ongoing studies.
In summary, our data suggest that: (1) the overexpression of FAK is sufficient to promote Ras-GTP loading in malignant astrocytoma cells cultured in aggregate suspension and when plated onto vitronectin as a monolayer; and (2) the association of p120RasGAP with FAK is characteristic of cells cultured in aggregate suspension, this association requires the Y397 residue of FAK, it results in a decrease in the level of p120Ras-GAP associated with active Ras, an increase in Ras activity (Ras-GTP loading) and an increase in anchorage-independent growth. These latter findings suggest a novel mechanism for FAK-mediated Ras activity in malignant astrocytoma cells. The association of FAK with p120RasGAP likely contributes to the elevated Ras activity and the rapid proliferation of malignant astrocytoma tumors that exhibit elevated levels of FAK expression and activity in vivo.
Materials and methods

Cells and biopsy samples
The OFAK5 and OFAK9 clones have been described previously (Wang et al., 2000) . The FRNK construct was a kind gift from Dr David Schlaepfer (Scripps Research Institute, La Jolla, CA, USA) (Sieg et al., 1999) . Stable cell lines expressing inducible FAK with a mutation of Y397 to F were established using the TET-ON Gene Expression System TM purchased from Clontech Laboratories, Inc. (Palo Alto, CA, USA). Briefly, U-251MG cells were transfected consecutively with the regulator plasmid, pTET-ON and PTRE2-FAK-397F with pTK-Hyg, or with PTRE2 and pTK-Hyg. Mouse FAK-397F cDNA with a c-Myc tag at the aminoterminus was described previously (Calalb et al., 1995) , and was cloned between EcoRV and XbaI of the polylinker. The DMRIE-C Reagent (Gibco BRL Life Technologies, Inc., Rockville, MD, USA) was used for liposome transfection of the U-251MG cells. Stable double transfectants were selected using 800 mg/ml of G418 (Mediatech, Inc., Herndon, VA, USA) and 800 mg/ml hygromycin B (Boehringer Mannheim Corp, Indianapolis, IN, USA), and clones were maintained in this selection medium.
FAK/p120RasGAP complex promotes Ras activity TP Hecker et al In all assays, cells were cultured in aggregate suspension, or as a monolayer on vitronectin. For both cell culture methods, cells were harvested with buffered EDTA from monolayer cultures propagated in media containing 10% FBS. For aggregate suspension culture, the cells were resuspended in serum-free media with 1% BSA, and then rotated for the indicated time at 371C with 5% CO 2 . Under these conditions, at 1 h, 74% of cells were in clusters of 45 cells (25% of cells in clusters of five to 10 cells, 31% of cells in clusters of 10 to 30 cells and 18% of cells in clusters of 430 cells), 14% of cells were paired and 12% were single cells. At 6 and 24 h, the percentage of single cells was lower and the number of cells per cluster was higher. Cell viability as estimated by the absence of trypan blue incorporation was 499% at 1, 6 and 24 h. The cells continued to synthesize DNA over 24 h, as assessed by labeling with bromodeoxyuridine. For monolayer culture, after harvesting with buffered EDTA as described above, the cells were resuspended in serum-free media with 1% BSA and then plated onto vitronectin-coated plates for the indicated time at 371C with 5% CO 2 .
Normal brain from patients with a seizure disorder and increased numbers of benign astrocytes and grade III anaplastic astrocytoma tumor biopsy samples were obtained from the Brain Tumor Bank, and the normal cortex and white matter from adult autopsy brains within 24 h of death were obtained from the Cooperative Tissue Network, both at the University of Alabama at Birmingham Hospital in accordance with the University Human Tissue Committee policies, Institutional Review Board exemption X980409003. Tumors were diagnosed and classified according to the criteria of the revised WHO Classification of Brain Tumors (Kleihues et al., 1993) .
Antibodies and reagents
The following antibodies were purchased as indicated: rabbit anti-FAK IgG, mAb anti-p190RhoGAP, and mAb anti-Ras from Upstate Biotechnology (Lake Placid, NY, USA); mAb anti-actin ascites from Sigma Chemical Co (St Louis, MO, USA); and mAb anti-p120RasGAP, mAb anti-HA, and mAb anti-c-Src that recognizes most Src family members and is referred to as mAb anti-Src in this paper from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Phosphospecific IgG-purified rabbit antibodies directed toward FAK [pY397], FAK [pY407], FAK [pY861], and FAK [pY925] were purchased from Biosource International (Camarillo, CA, USA). Raf-Ras-binding domain conjugated beads were purchased from Upstate Biotechnology; and N-SH2-p120Ras-GAP-conjugated beads, SH3-p120RasGAP-conjugated beads, and C-SH2-p120RasGAP-conjugated beads were purchased from Santa Cruz Biotechnology, Inc.
Western blotting, immunoprecipitations, and Ras activity assays
Tumor samples or cell lines were lysed in 1% NP-40 lysis buffer with protease inhibitors and the supernatant was stored at À701C, as described previously (Wang et al., 2000; Hecker et al., 2002) . For Western blots, equivalent amounts (mg) of protein from each lysate was electrophoresed on a 7.5% SDS-PAGE, transferred to Immobilon-P membrane (Millipore Corp.), and Western blotted as described previously (Wang et al., 2000) . For coimmunoprecipitation analysis or pull-down assays, equivalent microgram of protein lysate from each sample was incubated with sepharose-coupled antibody or N-SH2-, SH3-, C-SH2-conjugated p120RasGAP beads overnight at 41C, washed, subjected to 7.5% SDS-PAGE, transferred to Immobilon, and Western blotted. For Ras activity assays, equivalent amounts (microgram) of protein lysate from each sample was incubated with Raf-RBD-conjugated beads for 45 min at 41C, washed, subjected to 7.5% SDS-PAGE, transferred to Immobilon, and Western blotted with mAb anti-Ras that recognizes p21H, K-and N-Ras.
Anchorage-independent growth assays
Anchorage-independent growth assays were performed as described previously (Wang et al., 2000) . Briefly, cells were treated with doxycycline for 4 days, harvested and resuspended in 0.3% agar (plus/minus doxycycline), poured onto plates containing a layer of 0.5% agar (plus/minus doxycycline), and then maintained at 371C, 5% CO 2 for 14 days. The resulting colonies were counted with a colony being defined as 410 cells. Samples were assayed in replicas of three and the experiment was repeated twice.
